10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VBS (Vectus Biosystems Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Vectus Biosystems Ltd together

I guess you are interested in Vectus Biosystems Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Vectus Biosystems Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Vectus Biosystems Ltd’s Price Targets

I'm going to help you getting a better view of Vectus Biosystems Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vectus Biosystems Ltd

I send you an email if I find something interesting about Vectus Biosystems Ltd.

1. Quick Overview

1.1. Quick analysis of Vectus Biosystems Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Vectus Biosystems Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$-0.13
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.15
Return On Investment
-382.4%

For what price can you sell your share?

Current Price per Share
A$0.04
Expected price per share
A$0.04 - A$0.045
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vectus Biosystems Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.04
Intrinsic Value Per Share
A$-0.57 - A$-0.09
Total Value Per Share
A$-0.54 - A$-0.06

2.2. Growth of Vectus Biosystems Ltd (5 min.)




Is Vectus Biosystems Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$972k$2.3m-$1.3m-137.1%

How much money is Vectus Biosystems Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$2.2m$726.4k47.5%
Net Profit Margin-205.3%-254.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Vectus Biosystems Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#737 / 881

Most Revenue
#476 / 881

Most Profit
#272 / 881

Most Efficient
#574 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vectus Biosystems Ltd?

Welcome investor! Vectus Biosystems Ltd's management wants to use your money to grow the business. In return you get a share of Vectus Biosystems Ltd.

First you should know what it really means to hold a share of Vectus Biosystems Ltd. And how you can make/lose money.

Speculation

The Price per Share of Vectus Biosystems Ltd is A$0.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vectus Biosystems Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vectus Biosystems Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vectus Biosystems Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.03-71.8%-0.03-71.8%-0.04-105.8%-0.04-100.1%-0.04-104.7%-0.04-91.8%
Usd Book Value Change Per Share-0.03-62.5%-0.03-62.5%0.10243.8%0.0244.9%0.0132.0%0.004.4%
Usd Dividend Per Share0.000.0%0.000.0%0.05123.7%0.0383.1%0.05130.6%0.0379.3%
Usd Total Gains Per Share-0.03-62.5%-0.03-62.5%0.15367.6%0.05128.0%0.07162.6%0.0383.7%
Usd Price Per Share0.05-0.05-0.29-0.33-0.47-0.49-
Price to Earnings Ratio-1.75--1.75--6.80--7.23--10.26--12.24-
Price-to-Total Gains Ratio-2.01--2.01-1.96-6.78-7.46--4.40-
Price to Book Ratio2.76-2.76-6.65--0.82--6.60-60.13-
Price-to-Total Gains Ratio-2.01--2.01-1.96-6.78-7.46--4.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.02616
Number of shares38226
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.05
Usd Book Value Change Per Share-0.030.01
Usd Total Gains Per Share-0.030.07
Gains per Quarter (38226 shares)-955.892,485.87
Gains per Year (38226 shares)-3,823.559,943.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3824-3834798519589933
20-7647-765815971391619876
30-11471-1148223956587429819
40-15294-1530631942783239762
50-19118-1913039927979049705
60-22941-22954479121174859648
70-26765-26778558981370769591
80-30588-30602638831566579534
90-34412-34426718691762389477
100-38236-38250798541958199420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.013.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%4.09.00.030.8%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%5.00.05.050.0%5.00.08.038.5%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%6.07.00.046.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vectus Biosystems Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.038-0.0380%0.149-126%0.027-239%0.020-295%0.003-1524%
Book Value Per Share--0.0280.0280%0.066-58%0.004+658%-0.034+221%0.000+19514%
Current Ratio--3.4483.4480%4.142-17%2.698+28%2.856+21%4.513-24%
Debt To Asset Ratio--0.2660.2660%0.239+11%0.876-70%1.456-82%4.107-94%
Debt To Equity Ratio--0.3630.3630%0.314+16%0.226+61%0.135+168%0.615-41%
Dividend Per Share----0%0.076-100%0.051-100%0.080-100%0.049-100%
Enterprise Value--4372136.1004372136.1000%25286916.000-83%25020595.200-83%34851061.320-87%42427237.622-90%
Eps---0.044-0.0440%-0.065+48%-0.061+39%-0.064+46%-0.056+28%
Ev To Ebitda Ratio---1.926-1.9260%-7.929+312%-7.899+310%-10.773+459%-11.756+511%
Ev To Sales Ratio--3.8403.8400%18.668-79%19.144-80%75495.750-100%52018.685-100%
Free Cash Flow Per Share---0.039-0.0390%-0.044+13%-0.056+42%-0.057+45%-0.049+23%
Free Cash Flow To Equity Per Share---0.040-0.0400%0.031-228%-0.031-23%0.003-1499%0.001-4276%
Gross Profit Margin--1.6341.6340%1.482+10%1.481+10%1.440+13%1.490+10%
Intrinsic Value_10Y_max---0.091----------
Intrinsic Value_10Y_min---0.567----------
Intrinsic Value_1Y_max---0.040----------
Intrinsic Value_1Y_min---0.058----------
Intrinsic Value_3Y_max---0.097----------
Intrinsic Value_3Y_min---0.173----------
Intrinsic Value_5Y_max---0.125----------
Intrinsic Value_5Y_min---0.289----------
Market Cap2131132.000-93%4102429.1004102429.1000%23442452.000-83%26674668.867-85%38062017.520-89%40075937.260-90%
Net Profit Margin---2.053-2.0530%-2.546+24%-2.557+25%-4303.512+209482%-3087.032+150239%
Operating Margin---2.046-2.0460%-2.389+17%-2.324+14%-4148.889+202707%-3468.213+169434%
Operating Ratio--3.0463.0460%3.394-10%3.326-8%3090.090-100%2948.373-100%
Pb Ratio1.434-93%2.7602.7600%6.653-59%-0.819+130%-6.596+339%60.133-95%
Pe Ratio-0.911+48%-1.755-1.7550%-6.797+287%-7.231+312%-10.258+485%-12.236+597%
Price Per Share0.040-93%0.0770.0770%0.440-83%0.501-85%0.714-89%0.752-90%
Price To Free Cash Flow Ratio-1.014+48%-1.953-1.9530%-9.892+407%-7.868+303%-11.696+499%-15.441+691%
Price To Total Gains Ratio-1.046+48%-2.014-2.0140%1.957-203%6.779-130%7.460-127%-4.398+118%
Quick Ratio--3.3393.3390%4.075-18%2.633+27%2.787+20%4.902-32%
Return On Assets---1.154-1.1540%-0.745-35%-0.971-16%-0.893-23%-3.196+177%
Return On Equity---1.573-1.5730%-0.979-38%-0.851-46%-0.510-68%-3.611+130%
Total Gains Per Share---0.038-0.0380%0.225-117%0.078-149%0.099-138%0.051-175%
Usd Book Value--972082.710972082.7100%2304371.616-58%128268.802+658%-1179992.711+221%4956.077+19514%
Usd Book Value Change Per Share---0.025-0.0250%0.098-126%0.018-239%0.013-295%0.002-1524%
Usd Book Value Per Share--0.0180.0180%0.043-58%0.002+658%-0.022+221%0.000+19514%
Usd Dividend Per Share----0%0.049-100%0.033-100%0.052-100%0.032-100%
Usd Enterprise Value--2859377.0092859377.0090%16537643.064-83%16363469.261-83%22792594.103-87%27747413.405-90%
Usd Eps---0.029-0.0290%-0.042+48%-0.040+39%-0.042+46%-0.037+28%
Usd Free Cash Flow---1373861.724-1373861.7240%-1549894.326+13%-1947351.926+42%-1986837.089+45%-1693390.690+23%
Usd Free Cash Flow Per Share---0.026-0.0260%-0.029+13%-0.037+42%-0.037+45%-0.032+23%
Usd Free Cash Flow To Equity Per Share---0.026-0.0260%0.020-228%-0.020-23%0.002-1499%0.001-4276%
Usd Market Cap1393760.328-93%2682988.6312682988.6310%15331363.608-83%17445233.439-85%24892559.458-89%26209662.968-90%
Usd Price Per Share0.026-93%0.0500.0500%0.288-83%0.327-85%0.467-89%0.492-90%
Usd Profit---1529133.096-1529133.0960%-2255554.440+48%-2132205.462+39%-2176260.079+42%-1928172.112+26%
Usd Revenue--744692.796744692.7960%885865.890-16%826937.220-10%502881.005+48%259903.328+187%
Usd Total Gains Per Share---0.025-0.0250%0.147-117%0.051-149%0.065-138%0.033-175%
 EOD+3 -5MRQTTM+0 -0YOY+13 -273Y+18 -225Y+19 -2110Y+22 -18

3.3 Fundamental Score

Let's check the fundamental score of Vectus Biosystems Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.911
Price to Book Ratio (EOD)Between0-11.434
Net Profit Margin (MRQ)Greater than0-2.053
Operating Margin (MRQ)Greater than0-2.046
Quick Ratio (MRQ)Greater than13.339
Current Ratio (MRQ)Greater than13.448
Debt to Asset Ratio (MRQ)Less than10.266
Debt to Equity Ratio (MRQ)Less than10.363
Return on Equity (MRQ)Greater than0.15-1.573
Return on Assets (MRQ)Greater than0.05-1.154
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Vectus Biosystems Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.040
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Vectus Biosystems Ltd

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for cardiovascular fibrosis and systolic blood pressure, as well as treatments for kidney, liver, and lung fibrosis. Its lead compound is VB0004, currently under phase Ib clinical human trial, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure; VB4-A32 for the treatment of liver fibrosis; VB4-A79 for the treatment of lung fibrosis; and VB4-P5 for the treatment of renal fibrosis. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops Accugen consisting of AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in Rosebery, Australia.

Fundamental data was last updated by Penke on 2025-06-11 09:25:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vectus Biosystems Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -205.3% means that $-2.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vectus Biosystems Ltd:

  • The MRQ is -205.3%. The company is making a huge loss. -2
  • The TTM is -205.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-205.3%TTM-205.3%0.0%
TTM-205.3%YOY-254.6%+49.3%
TTM-205.3%5Y-430,351.2%+430,145.9%
5Y-430,351.2%10Y-308,703.2%-121,648.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-205.3%-88.2%-117.1%
TTM-205.3%-141.5%-63.8%
YOY-254.6%-182.9%-71.7%
3Y-255.7%-247.7%-8.0%
5Y-430,351.2%-338.6%-430,012.6%
10Y-308,703.2%-473.1%-308,230.1%
4.3.1.2. Return on Assets

Shows how efficient Vectus Biosystems Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • -115.4% Return on Assets means that Vectus Biosystems Ltd generated $-1.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vectus Biosystems Ltd:

  • The MRQ is -115.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -115.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-115.4%TTM-115.4%0.0%
TTM-115.4%YOY-74.5%-40.9%
TTM-115.4%5Y-89.3%-26.1%
5Y-89.3%10Y-319.6%+230.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-115.4%-11.1%-104.3%
TTM-115.4%-11.2%-104.2%
YOY-74.5%-11.0%-63.5%
3Y-97.1%-11.6%-85.5%
5Y-89.3%-11.8%-77.5%
10Y-319.6%-13.6%-306.0%
4.3.1.3. Return on Equity

Shows how efficient Vectus Biosystems Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • -157.3% Return on Equity means Vectus Biosystems Ltd generated $-1.57 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vectus Biosystems Ltd:

  • The MRQ is -157.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -157.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-157.3%TTM-157.3%0.0%
TTM-157.3%YOY-97.9%-59.4%
TTM-157.3%5Y-51.0%-106.3%
5Y-51.0%10Y-361.1%+310.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-157.3%-12.8%-144.5%
TTM-157.3%-14.2%-143.1%
YOY-97.9%-14.1%-83.8%
3Y-85.1%-16.6%-68.5%
5Y-51.0%-17.3%-33.7%
10Y-361.1%-19.4%-341.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vectus Biosystems Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vectus Biosystems Ltd is operating .

  • Measures how much profit Vectus Biosystems Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • An Operating Margin of -204.6% means the company generated $-2.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vectus Biosystems Ltd:

  • The MRQ is -204.6%. The company is operating very inefficient. -2
  • The TTM is -204.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-204.6%TTM-204.6%0.0%
TTM-204.6%YOY-238.9%+34.3%
TTM-204.6%5Y-414,888.9%+414,684.3%
5Y-414,888.9%10Y-346,821.3%-68,067.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-204.6%-227.4%+22.8%
TTM-204.6%-253.9%+49.3%
YOY-238.9%-201.7%-37.2%
3Y-232.4%-214.9%-17.5%
5Y-414,888.9%-339.9%-414,549.0%
10Y-346,821.3%-444.7%-346,376.6%
4.3.2.2. Operating Ratio

Measures how efficient Vectus Biosystems Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.05 means that the operating costs are $3.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 3.046. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.046. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.046TTM3.0460.000
TTM3.046YOY3.394-0.349
TTM3.0465Y3,090.090-3,087.044
5Y3,090.09010Y2,948.373+141.717
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0462.060+0.986
TTM3.0462.737+0.309
YOY3.3942.997+0.397
3Y3.3263.496-0.170
5Y3,090.0904.660+3,085.430
10Y2,948.3736.353+2,942.020
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vectus Biosystems Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vectus Biosystems Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.45 means the company has $3.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 3.448. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.448. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.448TTM3.4480.000
TTM3.448YOY4.142-0.694
TTM3.4485Y2.856+0.591
5Y2.85610Y4.513-1.657
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4483.670-0.222
TTM3.4483.745-0.297
YOY4.1424.121+0.021
3Y2.6984.623-1.925
5Y2.8565.733-2.877
10Y4.5136.143-1.630
4.4.3.2. Quick Ratio

Measures if Vectus Biosystems Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 3.34 means the company can pay off $3.34 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 3.339. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.339. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.339TTM3.3390.000
TTM3.339YOY4.075-0.736
TTM3.3395Y2.787+0.552
5Y2.78710Y4.902-2.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3392.906+0.433
TTM3.3393.128+0.211
YOY4.0753.786+0.289
3Y2.6334.308-1.675
5Y2.7875.703-2.916
10Y4.9026.411-1.509
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vectus Biosystems Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vectus Biosystems Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vectus Biosystems Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.27 means that Vectus Biosystems Ltd assets are financed with 26.6% credit (debt) and the remaining percentage (100% - 26.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 0.266. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.266. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.266TTM0.2660.000
TTM0.266YOY0.239+0.027
TTM0.2665Y1.456-1.190
5Y1.45610Y4.107-2.651
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2660.328-0.062
TTM0.2660.356-0.090
YOY0.2390.335-0.096
3Y0.8760.339+0.537
5Y1.4560.350+1.106
10Y4.1070.383+3.724
4.5.4.2. Debt to Equity Ratio

Measures if Vectus Biosystems Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 36.3% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 0.363. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.363. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.363TTM0.3630.000
TTM0.363YOY0.314+0.049
TTM0.3635Y0.135+0.227
5Y0.13510Y0.615-0.480
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3630.384-0.021
TTM0.3630.436-0.073
YOY0.3140.413-0.099
3Y0.2260.447-0.221
5Y0.1350.464-0.329
10Y0.6150.512+0.103
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vectus Biosystems Ltd generates.

  • Above 15 is considered overpriced but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A PE ratio of -1.75 means the investor is paying $-1.75 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vectus Biosystems Ltd:

  • The EOD is -0.911. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.755. Based on the earnings, the company is expensive. -2
  • The TTM is -1.755. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.911MRQ-1.755+0.843
MRQ-1.755TTM-1.7550.000
TTM-1.755YOY-6.797+5.043
TTM-1.7555Y-10.258+8.504
5Y-10.25810Y-12.236+1.978
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.911-2.125+1.214
MRQ-1.755-2.027+0.272
TTM-1.755-2.541+0.786
YOY-6.797-3.670-3.127
3Y-7.231-3.716-3.515
5Y-10.258-6.057-4.201
10Y-12.236-6.591-5.645
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vectus Biosystems Ltd:

  • The EOD is -1.014. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.953. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.953. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.014MRQ-1.953+0.938
MRQ-1.953TTM-1.9530.000
TTM-1.953YOY-9.892+7.939
TTM-1.9535Y-11.696+9.743
5Y-11.69610Y-15.441+3.746
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.014-3.030+2.016
MRQ-1.953-2.710+0.757
TTM-1.953-3.805+1.852
YOY-9.892-4.404-5.488
3Y-7.868-5.103-2.765
5Y-11.696-8.536-3.160
10Y-15.441-9.228-6.213
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vectus Biosystems Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.76 means the investor is paying $2.76 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vectus Biosystems Ltd:

  • The EOD is 1.434. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.760. Based on the equity, the company is underpriced. +1
  • The TTM is 2.760. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.434MRQ2.760-1.326
MRQ2.760TTM2.7600.000
TTM2.760YOY6.653-3.893
TTM2.7605Y-6.596+9.356
5Y-6.59610Y60.133-66.729
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4341.900-0.466
MRQ2.7601.861+0.899
TTM2.7602.162+0.598
YOY6.6532.465+4.188
3Y-0.8192.527-3.346
5Y-6.5963.682-10.278
10Y60.1334.351+55.782
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vectus Biosystems Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Net Interest Income  -716-358-1,074381-693543-15021868



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,026
Total Liabilities539
Total Stockholder Equity1,486
 As reported
Total Liabilities 539
Total Stockholder Equity+ 1,486
Total Assets = 2,026

Assets

Total Assets2,026
Total Current Assets1,843
Long-term Assets182
Total Current Assets
Cash And Cash Equivalents 809
Net Receivables 976
Inventory 1
Total Current Assets  (as reported)1,843
Total Current Assets  (calculated)1,786
+/- 57
Long-term Assets
Property Plant Equipment 182
Long-term Assets  (as reported)182
Long-term Assets  (calculated)182
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities535
Long-term Liabilities5
Total Stockholder Equity1,486
Total Current Liabilities
Short-term Debt 29
Accounts payable 187
Other Current Liabilities 319
Total Current Liabilities  (as reported)535
Total Current Liabilities  (calculated)535
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)5
Long-term Liabilities  (calculated)0
+/- 5
Total Stockholder Equity
Common Stock38,369
Retained Earnings -37,726
Accumulated Other Comprehensive Income 844
Total Stockholder Equity (as reported)1,486
Total Stockholder Equity (calculated)1,486
+/-0
Other
Capital Stock38,369
Cash and Short Term Investments 809
Common Stock Shares Outstanding 53,201
Current Deferred Revenue293
Liabilities and Stockholders Equity 2,026
Net Debt -780
Net Invested Capital 1,486
Net Working Capital 1,309
Property Plant and Equipment Gross 965
Short Long Term Debt Total 29



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-30
> Total Assets 
673
1,492
718
11,729
4,685
721
196
194
2,998
6,979
3,936
4,630
2,026
2,0264,6303,9366,9792,9981941967214,68511,7297181,492673
   > Total Current Assets 
396
1,275
523
11,669
4,600
654
150
159
2,919
6,906
3,729
4,457
1,843
1,8434,4573,7296,9062,9191591506544,60011,6695231,275396
       Cash And Cash Equivalents 
341
1,258
70
11,585
421
517
42
43
2,685
5,778
1,281
2,951
809
8092,9511,2815,7782,685434251742111,585701,258341
       Short-term Investments 
0
1,161
402
34
4,034
0
0
31
31
0
0
0
0
00003131004,034344021,1610
       Net Receivables 
48
0
0
44
96
78
25
32
79
977
2,318
1,434
976
9761,4342,3189777932257896440048
       Other Current Assets 
6
2
51
34
49
137
108
116
125
1,128
2,447
71
1,034
1,034712,4471,12812511610813749345126
   > Long-term Assets 
277
217
195
60
84
66
46
35
79
73
208
173
182
18217320873793546668460195217277
       Property Plant Equipment 
277
217
195
60
84
66
46
35
79
73
208
173
182
18217320873793546668460195217277
       Long-term Assets Other 
0
-217
-195
-60
0
-66
-46
-35
-79
-73
-208
-173
0
0-173-208-73-79-35-46-660-60-195-2170
> Total Liabilities 
1,177
516
662
511
936
604
2,453
3,924
9,709
9,878
8,358
1,106
539
5391,1068,3589,8789,7093,9242,4536049365116625161,177
   > Total Current Liabilities 
463
457
590
476
904
593
2,440
1,962
1,447
1,655
7,398
1,076
535
5351,0767,3981,6551,4471,9622,440593904476590457463
       Short-term Debt 
40
0
21
26
5
254
912
4
5
461
5,946
43
29
29435,9464615491225452621040
       Short Long Term Debt 
0
0
47
26
5
0
912
0
0
442
5,890
0
0
005,8904420091205264700
       Accounts payable 
134
118
277
172
330
74
981
1,120
606
328
120
220
187
1872201203286061,12098174330172277118134
       Other Current Liabilities 
268
339
292
304
541
265
530
821
790
823
1,275
814
319
3198141,275823790821530265541304292339268
   > Long-term Liabilities 
714
59
73
35
32
11
13
1,958
8,261
8,223
959
30
5
5309598,2238,2611,958131132357359714
       Long term Debt Total 
0
0
0
0
0
0
0
1,958
7,195
7,208
70
27
0
027707,2087,1951,9580000000
       Long term Debt 
700
26
26
5
0
0
0
1,958
7,160
7,191
0
0
0
0007,1917,1601,95800052626700
       Capital Lease Obligations 
0
0
0
0
5
0
0
8
56
35
126
70
29
2970126355680050000
       Other Liabilities 
15
33
46
29
32
11
13
5
0
2
72
3
0
037220513113229463315
> Total Stockholder Equity
-505
976
56
11,218
3,749
117
-2,256
-3,730
-6,710
-2,899
-4,421
3,524
1,486
1,4863,524-4,421-2,899-6,710-3,730-2,2561173,74911,21856976-505
   Common Stock
5,777
8,496
8,953
21,876
17,581
17,591
17,600
17,600
17,862
24,835
27,303
38,352
38,369
38,36938,35227,30324,83517,86217,60017,60017,59117,58121,8768,9538,4965,777
   Retained Earnings -37,726-35,632-32,183-28,189-24,843-21,847-20,251-17,663-13,869-10,658-9,002-7,520-6,282
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
0
0
0
0
188
394
1
1,066
1,013
887
-2,720
0
0-2,7208871,0131,066139418800000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,139
Cost of Revenue-59
Gross Profit1,1391,080
 
Operating Income (+$)
Gross Profit1,139
Operating Expense-3,409
Operating Income-2,271-2,271
 
Operating Expense (+$)
Research Development1,151
Selling General Administrative777
Selling And Marketing Expenses1,482
Operating Expense3,4093,409
 
Net Interest Income (+$)
Interest Income77
Interest Expense-9
Other Finance Cost-0
Net Interest Income68
 
Pretax Income (+$)
Operating Income-2,271
Net Interest Income68
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,399-1,142
EBIT - interestExpense = -2,338
-3,399
-2,329
Interest Expense9
Earnings Before Interest and Taxes (EBIT)-2,329-3,390
Earnings Before Interest and Taxes (EBITDA)-2,271
 
After tax Income (+$)
Income Before Tax-3,399
Tax Provision-0
Net Income From Continuing Ops-2,338-3,399
Net Income-2,338
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,409
Total Other Income/Expenses Net-1,128-68
 

Technical Analysis of Vectus Biosystems Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vectus Biosystems Ltd. The general trend of Vectus Biosystems Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vectus Biosystems Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Vectus Biosystems Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vectus Biosystems Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.045 < 0.045 < 0.045.

The bearish price targets are: 0.04.

Know someone who trades $VBS? Share this with them.👇

Vectus Biosystems Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vectus Biosystems Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vectus Biosystems Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Moving Average Convergence/Divergence (MACD) ChartVectus Biosystems Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vectus Biosystems Ltd. The current adx is .

Vectus Biosystems Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Relative Strength Index (RSI) ChartVectus Biosystems Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Stochastic Oscillator ChartVectus Biosystems Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Commodity Channel Index (CCI) ChartVectus Biosystems Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Chande Momentum Oscillator (CMO) ChartVectus Biosystems Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Williams %R ChartVectus Biosystems Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Average True Range (ATR) ChartVectus Biosystems Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily On-Balance Volume (OBV) ChartVectus Biosystems Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Money Flow Index (MFI) ChartVectus Biosystems Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vectus Biosystems Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Vectus Biosystems Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vectus Biosystems Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.040
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vectus Biosystems Ltd with someone you think should read this too:
  • Are you bullish or bearish on Vectus Biosystems Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vectus Biosystems Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vectus Biosystems Ltd

I send you an email if I find something interesting about Vectus Biosystems Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Vectus Biosystems Ltd.

Receive notifications about Vectus Biosystems Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.